[Chronic prostatitis and biofilm]

Infez Med. 2009 Jun:17 Suppl 1:10-6.
[Article in Italian]

Abstract

Nowadays, inflammatory prostatic diseases represent one of the main social and economic problems that affect male gender in our country. The disease's prevalence is estimated at 11-14% in European countries, and males aged between 20 and 50 years are the most affected subjects. Bacterial prostatitis is documented at a very low prevalence (7-13% of prostatitis overall considered) due to either reduced utilization of viral and bacteriological tests (Meares test, urethral swab, bacterial and viral PCR) or to the possibility that individual patients show a scarce expression of bacterial disease in biological fluids, because of intraglandular biofilm presence, with subsequent spreading of the sole plankton microrganisms. Actually, the presence of a biofilm may possibly represent the reason for difficult diagnoses and ineffective antibacterial treatments.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Biofilms* / drug effects
  • Chronic Disease
  • Ciprofloxacin / therapeutic use
  • Contraception Behavior / statistics & numerical data
  • Diet / statistics & numerical data
  • Disease Susceptibility
  • Drug Resistance, Microbial
  • Humans
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Ofloxacin / therapeutic use
  • Prospective Studies
  • Prostatitis / drug therapy
  • Prostatitis / epidemiology
  • Prostatitis / microbiology*
  • Risk Factors
  • Sexual Behavior / statistics & numerical data
  • Sexual Partners
  • Sexually Transmitted Diseases, Bacterial / epidemiology
  • Sexually Transmitted Diseases, Viral / epidemiology
  • Urinary Tract Infections / epidemiology
  • Urinary Tract Infections / microbiology
  • Urinary Tract Infections / virology
  • Young Adult

Substances

  • Ciprofloxacin
  • Ofloxacin